A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy
NCT07766642 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2026-08-14
Summary
This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily.
Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.
Conditions
- Difficulty Focusing
- Poor Concentration
- Poor Memory
- Low Energy
Interventions
- DIETARY_SUPPLEMENT
-
Auri Super Mushroom Daily Gummies For Kids
All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.
Sponsors & Collaborators
-
Citruslabs
collaborator INDUSTRY -
Auri Nutrition
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-13
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Brain Stimulation and Attention Control in Children With ADHD
NCT07182344 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Dietary Intake and Nutrient Status of Children With ADHD
NCT00434928 ·Status: COMPLETED
-
Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
NCT06215144 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Omega-3 Supplementation to ADHD Medication in Children
NCT02204410 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)
NCT03115671 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
NCT07717879 ·Status: RECRUITING ·Phase: PHASE3
-
Probiotic Supplement as Treatment for Students With ADHD
NCT02908802 ·Status: UNKNOWN ·Phase: NA
-
Tocotrienols for School-going Children With ADHD
NCT01855984 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity
NCT06594536 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multi-strain Probiotics for ADHD
NCT06226584 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder
NCT02315651 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
NCT03006367 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms
NCT05857956 ·Status: COMPLETED ·Phase: NA
-
Four-week Open-trial Extension TNS for ADHD
NCT03870737 ·Status: COMPLETED ·Phase: NA
-
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
NCT03460652 ·Status: COMPLETED ·Phase: PHASE3
-
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
NCT06685601 ·Status: RECRUITING ·Phase: NA
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder
NCT00418184 ·Status: COMPLETED ·Phase: PHASE2
-
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01069523 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD
NCT00712699 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
NCT02163915 ·Status: TERMINATED ·Phase: PHASE1
-
Effectiveness of a Mobile Neurofeedback for ADHD Youth
NCT04469335 ·Status: UNKNOWN ·Phase: NA
-
Evaluating a Digital Cognitive Training Intervention in Adults With ADHD
NCT07050225 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Examining the Impacts of Fidget Technology on Attention in Children With ADHD
NCT05384717 ·Status: COMPLETED ·Phase: NA
-
External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial
NCT06655610 ·Status: RECRUITING ·Phase: NA